Literature DB >> 1581117

Introduction to bone biology.

G A Rodan1.   

Abstract

Bone at the tissue level undergoes remodeling: it is continuously being resorbed and rebuilt (or formed). A negative balance between bone resorption and formation, frequently due to excessive resorption, is the basis of many bone diseases. Resorption is carried out by osteoclasts, which are specialized multinucleated cells of hemopoietic origin. Bone resorption takes place at a specialized area of the osteoclast cell membrane called "ruffled border," which comprises a sealed lysosomal compartment where the acidic pH solubilizes the mineral and the proteolytic enzymes digest the matrix. Among the agents that inhibit bone resorption, only calcitonin and bisphosphonate have been shown to act directly on osteoclasts. Other hormones and agents, which modulate bone turnover, probably act on the osteoblasts or cells of the osteoblast lineage. Osteoblasts are bone-forming cells, originating from cells resident in bone committed to the osteoblastic lineage. They synthesize and secrete most of the proteins of the bone matrix, including type I collagen and noncollagenous proteins. They possess high levels of alkaline phosphatase, which participates in mineralization. Proteins, produced by osteoblasts, spill over into the blood and are used as indicators of bone formation. In addition to the matrix-forming ability, cells of the osteoblastic family (osteocytes, lining cells, and maybe other cells) participate in the regulation of bone turnover. They respond to parathyroid hormone, glucocorticoids, vitamin D, sex steroids, insulin, prostaglandins, growth factors, and so on. There are a significant number of cytokines, that are locally produced and may control bone resorption. These include prostaglandins, IL1, TNF alpha, possibily IL6.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581117     DOI: 10.1016/s8756-3282(09)80003-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  42 in total

1.  Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo.

Authors:  Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker
Journal:  Stem Cells Dev       Date:  2010-10-17       Impact factor: 3.272

Review 2.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

3.  Beyond the skeleton: Cnidarian biomaterials as bioactive extracellular microenvironments for tissue engineering.

Authors:  Razi Vago
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

Review 4.  Cnidarians biomineral in tissue engineering: a review.

Authors:  Razi Vago
Journal:  Mar Biotechnol (NY)       Date:  2008-05-15       Impact factor: 3.619

Review 5.  Metabolic regulation of skeletal cell fate and function in physiology and disease.

Authors:  Nick van Gastel; Geert Carmeliet
Journal:  Nat Metab       Date:  2021-01-04

6.  Dual X-ray absorptiometry detects disease- and treatment-related alterations of bone density in prostate cancer patients.

Authors:  G L Smith; A P Doherty; L M Banks; J Dutton; L W Hanham; T J Christmas; R J Epstein
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Pharmacovigilance study of alendronate in England.

Authors:  Pipasha N Biswas; Lynda V Wilton; Saad A W Shakir
Journal:  Osteoporos Int       Date:  2003-04-23       Impact factor: 4.507

8.  Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids.

Authors:  Wendy Tseng; Jinxiu Lu; Gail A Bishop; Andrew D Watson; Andrew P Sage; Linda Demer; Yin Tintut
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

9.  Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns.

Authors:  L C de Sá Rodrigues; K E Holmes; V Thompson; C M Piskun; S E Lana; M A Newton; T J Stein
Journal:  Vet Comp Oncol       Date:  2015-02-03       Impact factor: 2.613

10.  Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.

Authors:  K E Holmes; V Thompson; C M Piskun; R A Kohnken; M K Huelsmeyer; T M Fan; T J Stein
Journal:  Vet Comp Oncol       Date:  2013-03-12       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.